Related Experiment Video
Updated: Jul 5, 2026
06:57
Use of an Integrated Low-Flow Anesthetic Vaporizer, Ventilator, and Physiological Monitoring System for Rodents
Published on: July 9, 2020
Regulatory challenges facing closed-loop anesthetic drug infusion devices
P J Manberg1, C M Vozella, S D Kelley
1Aspect Medical Systems, Norwood, Massachusetts, USA. pmanberg@aspectms.com
Clinical Pharmacology and Therapeutics
|May 9, 2008
Summary
Closed-loop anesthesia drug systems offer improved general anesthesia safety and consistency. However, regulatory, business, and clinical hurdles must be overcome for widespread adoption in practice.
Area of Science:
- Anesthesiology
- Medical Device Technology
- Pharmacology
Background:
- Closed-loop anesthesia drug infusion devices are being developed to enhance general anesthesia delivery.
- Research settings have shown the feasibility and potential benefits of these advanced systems.
Purpose of the Study:
- To evaluate the potential of closed-loop anesthesia systems.
- To identify barriers to the clinical implementation of these devices.
Main Methods:
- Review of existing research on closed-loop anesthesia systems.
- Analysis of regulatory, business, and clinical challenges.
Main Results:
- Closed-loop systems demonstrate promise for anesthesia consistency and safety.
- Significant regulatory, business, and clinical challenges impede market introduction.
Conclusions:
- Further development and resolution of identified issues are necessary for clinical integration.
- Successful market introduction requires addressing multifaceted barriers beyond technical feasibility.
Related Concept Videos
01:28Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices
Parenteral drug delivery systems play a crucial role in modern therapeutics by enabling the direct administration of drugs into the systemic circulation, bypassing the gastrointestinal tract. These systems are particularly valuable for poorly absorbed oral medications that are unstable in the digestive environment or require rapid onset or sustained therapeutic levels. Delivery is achieved through intravenous, intramuscular, or subcutaneous routes, each selected based on the drug's properties...
01:15Two-Compartment Open Model: IV Infusion
A two-compartment model is a vital tool in pharmacokinetics, providing an essential understanding of drug behavior, especially for those administered via zero-order intravenous infusion. This model outlines two compartments: the central compartment, where elimination occurs, and the peripheral compartment.
The model illustrates the decrease in plasma drug concentration from the central compartment with a specific equation. It shows that under steady-state conditions, the drug's input rate...
The model illustrates the decrease in plasma drug concentration from the central compartment with a specific equation. It shows that under steady-state conditions, the drug's input rate...
01:09One-Compartment Model: IV Infusion
Intravenous (IV) infusion is often utilized when continuous and controlled drug delivery is necessary, such as during surgery or in the treatment of chronic diseases. This method offers numerous advantages, including immediate drug action, precise control over dosage, and bypassing the first-pass metabolism.
The one-compartment model for IV infusion uses mathematical equations to describe the rate of change in drug quantity in the body. At steady-state or infusion equilibrium, the drug input...
The one-compartment model for IV infusion uses mathematical equations to describe the rate of change in drug quantity in the body. At steady-state or infusion equilibrium, the drug input...
01:24Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).